Cheaper HIV/AIDS drugs coming

Cheaper HIV/AIDS drugs coming.

The second coming of epigenetic drugs

L ike stem cell research, epigenetics has been promising radical new therapies, aimed at modifying the expression of target genes for a wide range of diseases. New drugs have been slow to materialize, however, largely because epigenetic mechanisms and their role in gene expression are more complex than originally thought. Nonetheless, clinically approved drugs that target epigenetic mechanisms ...

Programming cheaper dependable systems

Services must be dependable if they are to deliver the benefit that justifies the cost of deploying them. Services must be sufficiently dependable for their purpose, but no more costly than is necessary to achieve that level of dependability. This document describes some work on identifying programming concepts that can be exploited to reduce the cost of dependable systems. This includes both t...

Cheaper patents

The 1883 Patents Act in Britain provides perspective formodern patent policy reforms because it radically changed incentives for inventors by reducing filing fees by 84 percent. Patents increased 2.5-fold after the reform, which was evenly distributed across the geography of inventors, the organization of invention 0 September 2010 ccepted 15 October 2010 vailable online 30 November 2010

Drugs Cheaper Than Threepenny: The Market of Extremely Low-Priced Drugs within the National Health Insurance in Taiwan

While most drug policy researches paid attention to the financial impact of expensive drugs, the market situation of low-priced drugs in a country was seldom analyzed. We used the nationally representative claims datasets to explore the status within the National Health Insurance (NHI) in Taiwan. In 2007, a total of 12,443 distinct drug items had been prescribed 853,250,147 times with total exp...